Cargando…

Cytochrome b561 Serves as a Potential Prognostic Biomarker and Target for Breast Cancer

PURPOSE: Cytochrome b561 (CYB561) is a transmembrane protein and participates in ascorbate recycling and iron homeostasis. However, its role in breast cancer remains unclear. PATIENTS AND METHODS: In this study, we explored the expression pattern and prognostic value of CYB561 in breast cancer throu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiaochen, Zhao, Yangjing, Shao, Qixiang, Jiang, Guoqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722309/ https://www.ncbi.nlm.nih.gov/pubmed/35002301 http://dx.doi.org/10.2147/IJGM.S338878

Ejemplares similares

A phylogenetic study of cytochrome b561 proteins
por: Verelst, Wim, et al.
Publicado: (2003)

Comparison of insect and human cytochrome b561 proteins: Insights into candidate ferric reductases in insects
por: Holst, Jessica D., et al.
Publicado: (2023)

A Cytochrome b561 with Ferric Reductase Activity from the Parasitic Blood Fluke, Schistosoma japonicum
por: Glanfield, Amber, et al.
Publicado: (2010)

Spectral and Redox Properties of a Recombinant Mouse Cytochrome b561 Protein Suggest Transmembrane Electron Transfer Function
por: Bérczi, Alajos, et al.
Publicado: (2023)

TEADs serve as potential prognostic biomarkers and targets for human gastric cancer
por: Wang, Meng-huan, et al.
Publicado: (2022)

YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022)

FRI561 The Thyroid Trifecta
por: Kachhadia, Palak, et al.
Publicado: (2023)

CDK1 serves as a potential prognostic biomarker and target for lung cancer
por: Li, Mingyao, et al.
Publicado: (2020)

Séminaire Bourbaki : exposés 561–578
por: Dold, A, et al.
Publicado: (1981)

HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
por: Zhu, Xudong, et al.
Publicado: (2020)

CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022)

GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2023)

Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases
por: Liu, Yanqiu, et al.
Publicado: (2015)

UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic Cancer
por: Feng, Lei, et al.
Publicado: (2021)

Upregulation of lncRNA NR_046683 Serves as a Prognostic Biomarker and Potential Drug Target for Multiple Myeloma
por: Dong, Hang, et al.
Publicado: (2019)

Correction: Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases
por: Liu, Yanqiu, et al.
Publicado: (2016)

Correction: Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases
por: Liu, Yanqiu, et al.
Publicado: (2015)

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Tang, Kaihua, et al.
Publicado: (2023)

8 digit BCD 1248 to HP 561 B digital recorder interface
por: MeIman, P
Publicado: (1971)

Epidemiological characteristics of 561 cases of intracerebral hemorrhage in Chengdu, China
por: Yu, Kai, et al.
Publicado: (2021)

Glutathione Peroxidase GPX1 and Its Dichotomous Roles in Cancer
por: Zhao, Yangjing, et al.
Publicado: (2022)

Centromere Protein F (CENPF) Serves as a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma
por: Huang, Yugang, et al.
Publicado: (2021)

SUN-561 Abnormal Gestational Thyrotoxicosis in Twin Pregnancy
por: Shey, Susan, et al.
Publicado: (2019)

561 Ethnicity Influences Outcomes of Adult Burn Patients
por: DiPaolo, Nicola, et al.
Publicado: (2022)

METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas
por: Shu, Xin, et al.
Publicado: (2021)

Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer
por: Chen, Fei, et al.
Publicado: (2021)

ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma
por: ling, Jie, et al.
Publicado: (2022)

GRHL2 Expression Functions in Breast Cancer Aggressiveness and Could Serve as Prognostic and Diagnostic Biomarker for Breast Cancer
por: Bai, Xiaoyu, et al.
Publicado: (2022)

E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer
por: Zhou, Quan, et al.
Publicado: (2019)

PCAT6 May Be a Whistler and Checkpoint Target for Precision Therapy in Human Cancers
por: Jiang, Feng, et al.
Publicado: (2021)

561 Distribution of Asthma Mortality in Various Districts of Salvador, Brazil
por: Souza-Machado, Carolina, et al.
Publicado: (2012)

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2017)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2022)

Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer
por: Li, Zequn, et al.
Publicado: (2021)

SNRPD1/E/F/G Serve as Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Liu, Gaohua, et al.
Publicado: (2022)

Serum Nitric Oxide Level Serves as a Potential Prognostic Biomarker in ACLF Patients
por: Wang, Fei, et al.
Publicado: (2022)

ITGA3 Is Associated With Immune Cell Infiltration and Serves as a Favorable Prognostic Biomarker for Breast Cancer
por: Li, Yue, et al.
Publicado: (2021)

PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma
por: Jiang, Xiaocong, et al.
Publicado: (2021)

A test Unit for hewlett packard mod. 561 digital recorder
por: Egger, P
Publicado: (1970)

Cannot write session to /tmp/vufind_sessions/sess_gisviu9ek017md70gscprv0nrs